This invention provides a composition of at least one Bordetella antigen
and an effective adjuvant amount of interleukin-12 (IL-12), and uses thereof as
a vaccine against Bordetella infection. Methods for using IL-12 as an adjuvant
in combination with vaccines against Bordetella are also provided.